BSX Boston Scientific Earnings and EPS analysis

Relative Growth: Rel. Growth: 87

Relative Strength: Rel. Strength: 8

Relative Valuation: Rel. Valuation: 67

Relative Profitability: Rel. Profitability: 88

EPS in 2026 (TTM): $2.49

Last Report Period Date: Jun 30, 2026

Currently, BSX's 12-month EPS stands at $2.49, according to the most recent financial reports. Boston Scientific's earnings per share in 2025 was reported at $1.96, marking a rise from $1.26 in 2024. BSX recorded an EPS of $0.62 for the quarterly period ending on Jun 30, 2026.

BSX earnings history

Historical annual and quarterly earnings per share (EPS) data for Boston Scientific

EPS (TTM)

$2.49

EPS Growth YoY (Quarterly)

14.8%

EPS (Quarterly)

$0.62

EPS Growth (Quarterly)

-31.1%

In 2025, Boston Scientific's earnings per share was $1.96, a rise of 55.6% from $1.26 in 2024. The quarterly earnings per share for the period ending Jun 30, 2026, was $0.62, showing a 14.8% increase compared to the same quarter last year. The trailing twelve months EPS for BSX is $2.49 as of June 2026. Boston Scientific's full-year EPS for 2024 was $1.26, a 16.7% rise compared to the previous year.

BSX EPS vs price chart

BSX EPS growth history

Earnings per share growth rates over time

EPS Growth YoY (Quarterly)

14.8%

EPS growth YoY

55.6%

EPS growth 3Y avg

63.3%

EPS growth 5Y avg

N/A

Over the past 12 months, Boston Scientific has recorded an earnings per share growth rate of 14.8% (YoY, quarterly). Over an extended period, the company recorded an average EPS annual growth rate of 63.3% per year for the last 3 years.

BSX Earnings Waterfall

Breakdown of revenue, profit and net income for Boston Scientific

BSX Earnings vs Peers

What are the earnings of BSX compared to its peers

Stock name	Price to Earnings	EPS grwoth 1Y	EPS grwoth 3Y	EPS grwoth 5Y
BSX Boston Scientific Corp	20.23	55.6%	63.3%	N/A
MDT Medtronic Plc	24.89	3.3%	9.8%	6.9%
CNMD CONMED Corp	27.61	-64.6%	N/A	35.7%
SYK Stryker Corp	33.82	8%	10.9%	14.8%
MMSI Merit Medical Systems Inc	37.05	4.8%	18.3%	N/A
EW Edwards Lifesciences Corp	51.6	-73.6%	-9.2%	6.9%
TFX Teleflex Incorporated	N/A	-1,462.4%	N/A	N/A
ANGO Angiodynamics Inc	N/A	-6%	N/A	N/A

All data is based on quarterly TTM periods, unless otherwise specified.